D. Kumar et al. / European Journal of Medicinal Chemistry 45 (2010) 2806e2816
2815
[4] F. Vittorio, G. Ronsisvalle, A. Marrazzo, G. Blandini, Farmaco 50 (1995) 265e272.
[5] A. Nayyar, V. Monga, A. Malde, E. Coutinho, R. Jain, Bioorg. Med. Chem. 15
(2007) 626e640.
concentration of compound that produces a 99.9% end point
reduction [53].
[6] K. Sztanke, K. Pasterhak, J. Rzymowska, M. Sztanke, M. Kandefer-Szerszen, Eur.
J. Med. Chem. 43 (2) (2007) 404e419.
[7] M.A.A. Radhwan, E.A. Ragab, N.M. Sabry, S.M. El-Shenawy, Bioorg. Med. Chem.
15 (2007) 3832e3841.
5.5. QSAR studies
The details of molecular descriptors are available in literature
and therefore they are not discussed over here [29e34]. The
structures of benzylidene hydrazide derivatives are first pre-opti-
mized with the Molecular Mechanics Force Field (MMþ) procedure
included in Hyperchem 6.03 [54] and the resulting geometries are
further refined by means of the semiempirical method PM3
[8] A.C.L. Leite, R.S.D. Lima, D.R. Moreira, M.V. Cardoso, A.C.G.D. Brito, L.M.F.
D. Santos, M.Z. Hernandes, A.C. Kipustok, R.S.D. Lima, M.B.P. Soares, Bioorg.
Med. Chem. 14 (2006) 3749e3757.
[9] S. Gemma, G. Kukreja, C. Fattorusso, M. Persico, M.P. Romano, M. Altarelli,
L. Savini, G. Campiani, E. Fattorusso, N. Basilico, D. Taramelli, V. Yardley,
S. Butini, Bioorg. Med. Chem. Lett. 16 (2006) 5384e5388.
[10] L.Q. Al-Mawsawi, R. Dayam, L. Taheri, M. Witvrouw, Z. Debyser, N. Neamati,
Bioorg. Med. Chem. Lett. 17 (2007) 6472e6475.
[11] C. Hansch, T. Fujita, J. Am. Chem. Soc. 86 (1964) 1616e1626.
[12] A. Meerbach, R. Klocking, C. Meier, A. Lomp, B. Helbig, P. Wutzler, Antiviral Res.
45 (2000) 69e77.
[13] C. Romanutti, V. Castilla, C.E. Cato, M.B. Wachsman, Int. J. Antimicrob. Agents
29 (2007) 2667e2679.
(parametric Method-3). We chose
a gradient norm limit of
ꢀ
0.01 kcal/A for the geometry optimization. The lowest energy
structure was used for each molecule to calculate physicochemical
properties using TSAR 3.3 software for Windows [55]. Further, the
regression analysis was performed using the SPSS software package
[56]. The predictive powers of the equation were validated by
determination of cross-validated r2 (q2) using leave one out (LOO)
cross-validation method [57].
[14] H.Y. Kim, C. Patkar, R. Warrier, R. Kuhn, M. Cushman, Bioorg. Med. Chem. Lett.
15 (2005) 3207e3211.
[15] K. Andries, M. Moermans, T. Grevers, R. Willebroads, C. Sommen, J. Lacrampe,
F. Janssens, P.R. Wyde, Antiviral Res. 60 (2003) 209e219.
[16] V.A. Makarov, O.B. Riabova, V.G. Granik, H.M. Dahse, A. Stelzner, P. Wutzler,
M. Schmidtke, Bioorg. Med. Chem. Lett. 15 (2005) 37e39.
[17] P. Kumar, B. Narasimhan, D. Sharma, ARKIVOC xiii (2008) 159e178.
[18] P. Kumar, B. Narasimhan, D. Sharma, V. Judge, R. Narang, Eur. J. Med. Chem. 44
(2009) 1853e1863.
5.6. Evaluation of antiviral activity
[19] B. Narasimhan, U.R. Kothawade, D.S. Pharande, V.K. Mourya, A.S. Dhake, Indian
J. Chem. 42 (B) (2003) 2828e2834.
[20] B. Narasimhan, D. Belsare, P. Pharande, V.K. Mourya, A.S. Dhake, Eur. J. Med.
Chem. 39 (10) (2004) 827e834.
[21] B. Narasimhan, V.K. Mourya, A.S. Dhake, Bioorg. Med. Chem. Lett. 16 (2006)
3023e3029.
[22] B. Narasimhan, V.K. Mourya, A.S. Dhake, Pharm. Chem. J. 3 (2007) 120e125.
[23] B. Narasimhan, R. Narang, V. Judge, S. Ohlan, R. Ohlan, ARKIVOC xv (2007)
112e126.
[24] B. Narasimhan, V. Judge, R. Narang, S. Ohlan, R. Ohlan, Bioorg. Med. Chem. Lett.
17 (2007) 5836e5845.
[25] A. Kumar, B. Narasimhan, D. Kumar, Bioorg. Med. Chem. 15 (2007)
4113e4124.
[26] B. Narasimhan, A.S. Dhake, V.K. Mourya, ARKIVOC i (2007) 189e204.
[27] J.G. Cappucino, N. Sherman, Microbiology e A Laboratory Manual. Addison
Wesley Longman Inc, California, 1999, 263.
[28] S. Emami, M. Falhati, A. Banifafemi, A. Shafiee, Bioorg. Med. Chem. 12 (2004)
5881e5889.
[29] C. Hansch, A. Leo, S.H. Unger, K.H. Kim, D. Nikaitani, E.J. Lien, J. Med. Chem. 16
(11) (1973) 1207e1216.
[30] L.B. Kier, L.H. Hall, Molecular Connectivity in Chemistry and Drug Research.
Academic Press, New York, 1976.
[31] M. Randic, J. Am. Chem. Soc. 97 (1975) 6609e6615.
[32] A.T. Balaban, Chem. Phys. Lett. 89 (1982) 399e404.
[33] H. Wiener, J. Am. Chem. Soc. 69 (1947) 17e20.
[34] M. Randic, Croat. Chem. Acta 66 (1993) 289e312.
[35] J. Dai, C. Sun, S. Han, L. Wang, Bull. Environ. Contam. Toxicol. 62 (1999)
530e538.
5.6.1. Antiviral assay
The antiviral screening of benzylidene/2-chlorobenzylidene
hydrazides (1e20) was performed against Feline Corona virus
(FIPV), Feline Herpes virus in CRFK cell culture; Herpes simplex
virus-1 (KOS) [HSV-1 KOS], Herpes simplex virus-2 (G) [HSV-2G],
Vaccinia virus [VV], Vesicular stomatitis virus [VSV], Herpes
simplex virus-1 TKꢀ KOS ACVr [HSV-1 TKꢀ KOS ACVr] in HEL cell
cultures; Vesicular stomatitis virus (VSV), Coxsackie virus B4 [CV-
B4], Respiratory syncytial virus [RSV] in HeLa cell cultures; Para-
influenza-3 virus [PI-3V], Reovirus-1 [RV-1], Sindbis virus [SV],
Coxsackie virus B4 [CV-B4], Punta Toro virus [PTV] in Vero cell
cultures; Influenza A virus H1N1 subtype, Influenza A virus H3N2
subtype and influenza B virus in MDCK cell cultures and the
results were expressed as the 50% effective concentration (EC50).
Cells, grown to confluency in 96-well plates, were infected with
100 CCID50 of virus, one CCID50 being the 50% cell culture
infective dose. After an adsorption period of 2 h at 37 ꢁC, virus
was removed and serial dilutions of the compounds were added.
The cultures were further incubated at 37 ꢁC for 3 days, until
complete CPE was observed in the infected and untreated virus
control.
[36] V. Lather, A.K. Madan, Bioorg. Med. Chem. 13 (2005) 1599e1604.
[37] A. Golbraikh, A. Tropsha, J. Mol. Graph. Model. 20 (2002) 269e276.
[38] B. Narasimhan, M. Kumari, N. Jain, A.S. Dhake, C. Sundaravelan, Bioorg. Med.
Chem. Lett. 16 (2006) 4951e4958.
[39] S. Bajaj, S.S. Sambi, A.K. Madan, Croat. Chem. Acta 78 (2) (2005) 165e174.
[40] P. Sharma, A. Kumar, M. Sharma, Eur. J. Med. Chem. 41 (2006) 833e840.
[41] S.A. Hatya, E. Aki-sener, B. Tekiner-Gulbas, I. Yildiz, O. Temiz-Arpaci, I. Yalcin,
N. Altanlar, Eur. J. Med. Chem. 41 (2006) 1398e1404.
5.6.2. Cytotoxic assay
The cytotoxicity of the compounds was evaluated in parallel
with their antiviral activity in uninfected cells, and is expressed as
minimum cytotoxic concentration to cause a microscopically
detectable alteration of normal cell morphology (HEL cells, HeLa
cells, CRFK cells, MDCK cells and Vero cells).
[42] A. Kumar, P. Sharma, V.K. Gurram, N. Rane, Bioorg. Med. Chem. Lett. 16 (2006)
2484e2491.
[43] F.J. Prado-Prado, H. Gonzalez-Diaz, O.M.D.L. Vega, F.M. Ubeira, K.C. Chou,
Bioorg. Med. Chem. 16 (11) (2008) 5871e5880.
Acknowledgements
[44] H. Gonzalez-Diaz, F.J. Prado-Prado, J. Comput. Chem. 29 (4) (2008) 656e667.
[45] M. Cruz-Monteagudo, H. Gonzalez-Diaz, G. Aguero-Chapin, L. Santana,
F. Borges, E.R. Dominguez, G. Podda, E. Uriarte, J. Comput. Chem. 28 (11)
(2007) 1909e1923.
[46] H. Gonzalez-Diaz, S. Vilar, L. Santana, E. Uriarte, Curr. Top. Med. Chem. 7 (10)
(2007) 1015e1029.
We would like to thank Mrs. Leentje Persoons, Rega Institute for
Medical Research, Belgium for her excellent technical assistance in
the evaluation of antiviral activity.
[47] H. Gonzalez-Diaz, Y. Gonzalez-Diaz, L. Santana, F.M. Ubeira, E. Uriarte, Pro-
teomics 8 (4) (2008) 750e778.
References
[48] M. Sortino, P. Delgado, S. Jaurez, J. Quiroga, R. Abonia, B. Insuasey, M.N. Rodero,
F.M. Garibotto, R.D. Enriz, S.A. Zaccino, Bioorg. Med. Chem. Lett. 15 (2007)
484e494.
[49] O.O. Guven, T. Erdogan, H. Goker, S. Yildiz, Bioorg. Med. Chem.17(2007)2233e2236.
[50] P. Sharma, N. Rane, V.K. Gurram, Bioorg. Med. Chem. Lett.14 (2004) 4185e4190.
[51] A.M. De Palma, W. Heggermont, P. Leyssen, G. Purstinger, E. Wimmer, E. De
Clercq, A. Rao, A.M. Monforte, A. Chimirri, J. Neyts, Biochem. Biophys. Res.
Commun. 353 (2007) 628e632.
[1] K.G. Yu, D.H. Li, C.H. Zhou, J.L. Diao, Chin. Chem. Lett. 20 (2009) 411e414.
[2] I.R. Ezabadi, C. Camoutsis, P. Zoumpoulakis, A. Geronikaki, M. Sokovic,
J. Glamocilija, A. Ciric, Bioorg. Med. Chem. 16 (2008) 1150e1161.
[3] S.T. Murphy, H.L. Case, E. Ellsworth, S. Hagen, M. Huband, T. Joannides,
C. Limberakis, K.R. Marotti, A.M. Ottolini, M. Rauckhorst, J. Starr, M. Stier,
C. Taylor, T. Zhu, A. Blaser, W.A. Denny, G.L. Lu, J.B. Smaillc, F. Rivault, Bioorg.
Med. Chem. Lett. 17 (2007) 2150e2155.